Telomir Pharmaceuticals, Inc. - COM (TELO)

Historical Portfolio Holders from Q1 2024 to Q3 2024

All holders as of June 30, 2024: Q2 2024
Type / Class: Equity / COM
Shares, excl. options Q2 2024: 361K
Holdings value Q2 2024: $1.74M
Value change Q2 2024: +$1.33M
Grand Portfolio weight change Q2 2024: +0%
Number of holders: 24
Number of buys Q2 2024: 2
Number of sells Q2 2024: -1
Average buys Q2 2024 %: +0%
Average sells Q2 2024 %: 0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q3	63.2K	$406K	+$97.5K			$6.41	4
2024 Q2	361K	$1.74M	+$1.33M			$4.81	24
2024 Q1	79.9K	$413K	+$413K			$5.15	7